Navigation Links
Medarex Announces 2008 Third Quarter Financial Results
Date:10/30/2008

g statements preceded by, followed by, or that include the words "potential"; "preliminary"; or similar statements are forward-looking statements. Medarex disclaims any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of antibody products in patients, uncertainties related to product manufacturing, the need for additional capital, compliance with regulatory requirements, risks associated with the use of hazardous substances and risks associated with the enforceability of our patents, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such development efforts will succeed or that developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo, UltiMAb(R) and HuMAb(TM) are trademarks of Medarex, Inc. All rights are reserved.

MEDAREX, INC.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

Three Months Ended Nine Months Ended

September 30, September 30,

(unaudited) (unaudited)

2008 2007 2008 2007

<
'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Europe, NEWPORT NEWS, Va., May 6 Dilon ... Europeenne) approval for the,commercial sale of the Dilon 6800 ... is a high-resolution gamma camera that enables,molecular imaging of ... "I am delighted that our high technology camera ...
... today announced that,it has enhanced its leadership ... in the United States and abroad as ... this development. Jacqueline Hall has been,appointed global ... Ph.D. has been appointed vice president and ...
... to Commercialize Leading OAB Drug in China, ... Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or ... ("CTA") for Enablex(R),(Darifenacin) was officially accepted by China,s ... a key SFDA requirement prior to,pursuing a clinical ...
Cached Biology Technology:MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 2MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 3BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 2BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 3
(Date:4/24/2014)... is a commercially important sugar used as a ... compound for synthesizing riboflavin and several antiviral drugs. ... increase the bacteria,s ability to produce D-ribose is ... production of this valuable chemical, as described in ... peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
(Date:4/24/2014)... identified the structural features that enable the innate ... RNAs in living cells. , When viruses infect ... hijack cellular resources for the production of viral ... molecules that are delivered directly to (in the ... the host cell, and provide the blueprints for ...
(Date:4/24/2014)... With a new generation of military veterans returning home ... become a prominent concern in American medical institutions and ... 35 percent of personnel deployed to Iraq and Afghanistan ... South Carolina School of Medicine is shedding light on ... and surprising ways. , The rise in PTSD has ...
Breaking Biology News(10 mins):Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3
... the breakdown of cognition processes and typical emotional and ... believe that several genes are associated with an increased ... the disease by itself. It is likely that interactions ... to develop and that epigenetic change also plays a ...
... Studies and the Woodrow Wilson International Center for Scholars ... Science Foundation (NSF) to help realize potential benefits and ... The grant is supported jointly by three ... Biology, the Division of Environmental Biology, and the Engineering ...
... generally deleterious, even in flowering plants. Since inbreeding raises ... be expressed, inbred progeny suffer from reduced viability. ... reject their own pollen, thereby preventing inbreeding despite the ... that involves the interaction of a gene that tags ...
Cached Biology News:How does inbreeding avoidance evolve in plants? 2
... Start up kit. Includes configured Laptop PC ... 2 MultiBlock satellite thermal cyclers (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
Glycerokinase; from Bacillus stearothermophilus...
A compact, high-speed single tube reader unit designed for benchtop 2D barcode reading. The unit can be used with all of ABgene's 2D barcoded tubes, including the 2ml CryoCode tube....
... Ascent FL is equipped ... luminometric measurement technologies that ... of advanced features of ... Ascent. Fluoroskan Ascent FL ...
Biology Products: